Toxicogenomic analysis of mainstream tobacco smoke-exposed mice reveals repression of plasminogen activator inhibitor-1 gene in heart

Inhalation Toxicology

Volumn 21, Issue 1, 2009, Pages 78-85

  Halappanavar, Sabina ^a   Stampfli, Martin R ^b   Berndt Weis, Lynn ^a   Williams, Andrew ^a   Douglas, George R ^a   Yauk, Carole L ^a  

^a HEALTH CANADA   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; NEUROSERPIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TOBACCO SMOKE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE REPRESSION; MALE; MICROSOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FOLDING; PROTEIN FUNCTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CARDIOVASCULAR DISEASES; CYTOCHROME P-450 CYP1A1; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEART; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; MICROSOMES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLASMINOGEN ACTIVATOR INHIBITOR 1; TOBACCO SMOKE POLLUTION; TOXICOGENETICS; UP-REGULATION;

MUS; NICOTIANA TABACUM;

EID: 58149120854     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.1080/08958370802209165     Document Type: Article

References (40)

1. Agren, A., Kolmert, T., Wiman, B., and Schulman, S. 2007. Low PAI-1 activity in relation to the risk for perioperative bleeding complications in transurethral resection of the prostate. Thromb. Res. 119:715-721.
2. Benjamini, Y., and Hochberg, Y. 1995. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57:289-300.
3. Carmeliet, P., Kieckens, L., Schoonjans, L., Ream, B., van Nuffelen, A., Prendergast, G., Cole, M., Bronson, R., Collen, D., and Mulligan, R. C. 1993a. Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization. .J Clin. Invest. 92:2746-2755.
4. Carmeliet, P., Stassen, J. M., Schoonjans, L., Ream, B., van den Oord, J. J., DeMol, M., Mulligan, R. C., and Collen, D. 1993b. Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis. J. Clin. Invest. 92:2756-2760.
5. Chen, L., Chester, M., and Kaski, J. C. 1995. Clinical factors and angiographic features associated with premature coronary artery disease. Chest 108:364-369.
6. Cui, X., Hwang, J. T., Qiu, J., Blades, N. J., and Churchill, G. A. 2005. Improved statistical tests for differential gene expression by shrinking variance components estimates. Biostatistics 6:59-75.
7. Dellas, C., and Loskutoff, D. J. 2005. Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease. Thromb. Haemost. 93:631-640.
8. Dong, G., Schulick, A. H., DeYoung, M. B., and Dichek, D. A. 1996. Identification of a cis-acting sequence in the human plasminogen activator inhibitor type-1 gene that mediates transforming growth factor-beta1 responsiveness in endothelium in vivo. J. Biol. Chem. 271:29969-29977.
9. Dong, H., Wade, M., Williams, A., Lee, A., Douglas, G. R., and Yauk, C. 2005. Molecular insight into the effects of hypothyroidism on the developing cerebellum. Biochem. Biophys. Res. Commun. 330:1182-1193.
10. Flotho, C., Paulun, A., Batz, C., and Niemeyer, C. M. 2007. AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies. Br. J. Haematol. 138:644-650.
11. Furuyama, A., Hirano, S., Koike, E., and Kobayashi, T. 2006. Induction of oxidative stress and inhibition of plasminogen activator inhibitor-1 production in endothelial cells following exposure to organic extracts of diesel exhaust particles and urban fine particles. Arch. Toxicol. 80:154-162.
12. Gils, A., and Declerck, P. J. 2004. The structural basis for the pathophysiological relevance of PAI-I in cardiovascular diseases and the development of potential PAI-I inhibitors. Thromb. Haemost. 91:425-437.
13. Hamsten, A., de Faire, U., Walldius, G., Dahlen, G., Szamosi, A., Landou, C., Blomback, M., and Wiman, B. 1987. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 2:3-9.
14. Hautamaki, R. D., Kobayashi, D. K., Senior, R. M., and Shapiro, S. D. 1997. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277:2002-2004.
15. Juhan-Vague, I., Valadier, J., Alessi, M. C., Aillaud, M. F., Ansaldi, J., Philip-Joet, C., Holvoet, P., Serradimigni, A., and Collen, D. 1987. Deficient t-PA release and elevated PAinhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Thromb. Haemost. 57:67-72.
16. Kerr, M. K. 2003. Design considerations for efficient and effective microarray studies. Biometrics 59:822-828.
17. Kluft, C., Verheijen, J. H., Jie, A. F., Rijken, D. C., Preston, F. E., Sue-Ling, H. M., Jespersen, J., and Aasen, A. O. 1985. The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scand. J. Clin. Lab. Invest. 45:605-610.
18. Loskutoff, D. J., Sawdey, M., and Mimuro, J. 1989. Type 1 plasminogen activator inhibitor. Prog. Hemost. Thromb. 9:87-115.
19. Montgomery, D. C. 2001. Design and analysis of experiments, 5th ed. New York: John Wiley & Sons.
20. Newby, D. E., Wright, R. A., Labinjoh, C., Ludlam, C. A., Fox, K. A., Boon, N. A., and Webb, D. J. 1999. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: A mechanism for arterial thrombosis and myocardial infarction. Circulation 99:1411-1415.
21. Njolstad, I., Arnesen, E., and Lund-Larsen, P. G. 1996. Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study. Circulation 93:450-456.
22. Ozdemir, O., Karaaslan, Y., Ozcebe, O., Dundar, S., and Kirazli, S. 1992. The acute effect of smoking on platelet and endothelial release reaction is suppressed in chronic smokers. Thromb. Res. 65:263-274.
23. Pasten, C., Olave, N. C., Zhou, L., Tabengwa, E. M., Wolkowicz, P. E., and Grenett, H. E. 2007. Polyphenols downregulate PAI-1 gene expression in cultured human coronary artery endothelial cells: Molecular contributor to cardiovascular protection. Thromb. Res. 121:59-65.
24. Peterfy, M., Phan, J., Xu, P., and Reue, K. 2001. Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat. Genet. 27:121-124.
25. Price, J. F., Mowbray, P. I., Lee, A. J., Rumley, A., Lowe, G. D., and Fowkes, F. G. 1999. Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. Eur. Heart J. 20:344-353.
26. Proctor, R. N. 2004. The global smoking epidemic: a history and status report. Clin. Lung Cancer 5:371-376.
27. R Development Core Team. 2005. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
28. Santamaria, A., Borrell, M., Mateo, J., Vallve, C., and Fontcuberta, J. 2007. What is the clinical impact of low plasminogen activator inhibitor-1 (PAI-1) activity? A case report and study of the incidence of low PAI-1 antigen in a healthy population. J. Thromb.. Haemost. 5:1565-1566.
29. Sawdey, M. S., and Loskutoff, D. J. 1991. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta. J. Clin. Invest. 88:1346-1353.
30. Schneiderman, J., Sawdey, M. S., Keeton, M. R., Bordin, G. M., Bernstein, E. F., Dilley, R. B., and Loskutoff, D. J. 1992. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc. Natl. Acad. Sci. USA 89:6998-7002.
31. Sherman, C. B. 1991. Health effects of cigarette smoking. Clin. Chest Med. 12:643-658.
32. Simani, A. S., Inoue, S., and Hogg, J. C. 1974. Penetration of the respiratory epithelium of guinea pigs following exposure to cigarette smoke. Lab. Invest. 31:75-81.
33. Thirman, M. J., Albrecht, J. H., Krueger, M. A., Erickson, R. R., Cherwitz, D. L., Park, S. S., Gelboin, H. V., and Holtzman, J. L. 1994. Induction of cytochrome CYPIA1 and formation of toxic metabolites of benzo[a]pyrene by rat aorta: A possible role in atherogenesis. Proc. Natl. Acad. Sci. USA 91:5397-401.
34. Umegaki, N., Tamai, K., Nakano, H., Moritsugu, R., Yamazaki, T., Hanada, K., Katayama, I., and Kaneda, Y. 2007. Differential regulation of karyopherin alpha 2 expression by TGF-beta1 and IFN-gamma in normal human epidermal keratinocytes: Evident contribution of KPNA2 for nuclear translocation of IRF-1. J. Invest. Dermatol. 127:1456-1464.
35. Vaughan, D. E. 2005. PAI-1 and atherothrombosis. J. Thromb. Haemost. 3:1879-1883.
36. Wang, Y., Barbacioru, C., Hyland, F., Xiao, W., Hunkapiller, K. L., Blake, J., Chan, F., Gonzalez, C., Zhang, L., and Samaha, R. R. 2006. Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays. BMC Genom. 7:59.
37. Wu, H., Kerr, K. M., Cui, X., and Churchill, G. A. 2003. MAANOVA: A software package for the analysis of spotted cDNA microarray experiments. In The analysis of gene expression data: Methods and software, eds. G. E. Parmigiani, E. S. Garrett,. R. A. Irizarry, and S. L. Zeger, pp. 313-431. New York: Springer-Verlag.
38. Xiang, G., Schuster, M. D., Seki, T., Witkowski, P., Eshghi, S., and Itescu, S. 2005. Downregulated expression of plasminogen activator inhibitor-1 augments myocardial neovascularization and reduces cardiomyocyte apoptosis after acute myocardial infarction. J. Am. Coll. Cardiol. 46:536-541.
39. Yang, Y. H., Dudoit, S., Luu, P., Lin, D. M., Peng, V., Ngai, J., and Speed, T. P. 2002. Normalization for cDNA microarray data:Arobust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30:e15.
40. Yauk, C. L., Berndt, M. L., Williams, A., Rowan-Carroll, A., Douglas, G. R., and Stampfli, M. R. 2007. Mainstream tobacco smoke causes paternal germ-line DNA mutation. Cancer Res. 67:5103-106.